Letters to the Editor  by Testa, Luca et al.
Letters to the
Editor
To the Editor:
We carefully read the interesting article by
Bainbridge and colleagues1 comparing, by
means of a meta-analytic approach, the
available evidence on off-pump coronary
artery bypass surgery (OPCABG) with per-
cutaneous coronary intervention (PCI). Six
trials involving 989 patients were included.
All but 1 trial included only patients with
isolated proximal left anterior descending
disease. Only 1 trial used paclitaxel or
sirolimus-eluting stents. The authors con-
cluded that OPCABG is associated with
better short-term and midterm clinical out-
comes but also with an increased length of
hospital stay.
The authors correctly suggested pro-
jecting the results to a population larger
than that of the included studies. For
example, for every 1000 low-risk patients
undergoing OPCABG, there will be ap-
proximately 105 fewer patients with re-
current angina, 143 fewer patients with
target vessel failure, and 125 fewer pa-
tients with major adverse cardiovascular
events (MACE) at 1 to 5 years. These
statements are consistent with the findings
of the meta-analysis, but some issues de-
serve attention and a deeper examination to
avoid possibly misleading conclusions.
One of our concerns is the reliability of
the results considering the widespread dif-
fusion of drug-eluting stents (DES), which
greatly reduced the risk of restenosis com-
pared with bare metal stents in short-, mid-,
and long-term follow-ups. Only 1 study
adopted DES and kept the double antiplate-
let therapy for only 6 months. A high rate
of restenosis probably fixed the difference
observed in the rate of target vessel failure
and then of MACE. It is conceivable, and
the authors correctly did not exclude such a
possibility, that the results of a comparison
between DES and OPCABG may be dif-
ferent particularly when considering the
risk of recurrent angina and reintervention,
and probably of MACE, although there is
no clear evidence of the superiority of DES
over bare metal stents for this point.2
On analysis of Table 3,1 some points
require further in-depth evaluation. All of
the end points that significantly differ be-
tween OPCABG and PCI can be ascribed
to the “restenosis” phenomenon because
death, myocardial infarction, and stroke did
not significantly differ. The risk of death, in
particular, deserves a larger discussion.
The difference did not reach statistical sig-
nificance, and the confidence interval was
wide (ie, the events were few and/or the
population was small and underpowered),
but, in absolute terms, and this point is not
negligible in our opinion, such risk was
more than 3-fold higher with OPCABG
than PCI in the hospital and approximately
2-fold higher at 6 months and at 1 to 5
years. Thus, we think that it is at least
questionable to state that OPCABG is as
safe as PCI.
Moreover, most of the included popula-
tion had isolated proximal left anterior de-
scending disease: This point is crucial. As
available evidence referred to a medical
“environment” in which the use of DES is
widespread, current guidelines advise
against PCI only in the setting of left main
disease, isolated or associated with a larger
coronary disease.2 Evidence-based medi-
cine is mandatory.
The results of such a well-conducted,
well-written meta-analysis would probably
have been useful as an interpretative tool a
few years ago. Today, the continuous
progress of the percutaneous approach to cor-
onary artery disease in terms of materials and
techniques allows the physician to propose a
less-invasive approach with an excellent
chance for good results; thus, it may be mis-
leading to state the “superiority” of OP-
CABG in the “Conclusion” section.
We think that an updated comparison of
OPCABG versus PCI with DES is neces-
sary, but one point finally remains: One of
the duties of any physician is to suggest a
range of possibilities (when available) to
treat the same disease.
In our experience of research3 and med-
ical practice in different countries, one of
the most important things to take into ac-
count is the patient’s will. Even if this
matter is not “evidence based,” we think
that when choosing between two strategies
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everyone would prefer the less-invasive
one. This issue is not quantifiable; on the
other hand, suggesting the superiority of
the OPCABG over PCI for a single-vessel
disease on the basis of a non-updated anal-
ysis may be misleading for those physi-
cians aiming at explaining a complete
“state of the art.”
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Fixed subaortic stenosis
To the Editor:
We read with great interest the article en-
titled “Geometry of the Left Ventricular
Outflow Tract in Fixed Subaortic Stenosis
and Intact Ventricular Septum: An Echo-
cardiographic Study in Children and
Adults.”1 We have a few points to discuss.
First, we agree with the authors in
choosing the wider mitral–aortic separa-
tion, steeper aortoseptal angle, smaller left
ventricular outflow tract width, aortic valve
dextroposition, increased left ventricle wall
thickness, increased septal thickness, and
indexed left ventricular end-diastolic and
end-systolic diameters as the echocardio-
graphic parameters to check in cases of
subaortic stenosis.
Second, we think that left ventricular
outflow tract obstruction in cases of Shone
complex is a true challenge. We prefer not
to intervene early, giving the heart and
body time to grow, which is contrary to the
general preference to intervene early in the
other cases of subaortic stenosis. Discrete
subaortic stenosis can be cured in most
patients by membranectomy associated
with myotomy or myectomy. Because the
anatomic substrate is not addressed by
these surgical techniques, however, recur-
rences are likely during long-term follow-
up, particularly in patients who have under-
gone previous operations for an aortic
coarctation and in patients with less than
optimal relief of the left ventricular outflow
tract gradient. In this subset of patients, the
optimal surgical technique remains to be
described. Intraoperative recording of the
left ventricle–aorta gradient by transesoph-
ageal echocardiography or pressure mea-
surement remains an important tool for
more aggressive subaortic resection in case
of a residual gradient greater than 30 mm
Hg. According to the size and function of
the aortic valve, the Ross–Konno procedure
or the modified Konno procedure by patch
septoplasty seems to be the appropriate sur-
gical technique. Tunnel subaortic stenosis
represents a more severe and challenging
cause of left ventricular outflow tract ob-
struction, particularly when symptoms start
early in life. Although multivariate analysis
did not demonstrate this anatomic form as
an independent risk factor for overall mor-
tality and recurrence rates, in univariate
analyses it was associated with a higher
overall mortality rate and reoperation rate,
along with other factors of the Shone com-
plex (ie, hypoplastic aortic anulus, mitral
stenosis, and existence of coarctation).2
Third, we have a remark on Table 3. We
expected the indexed left ventricular end-
systolic dimension to decrease postopera-
tively especially in group 1, which was not
the case. The left ventricular end-systolic
dimension increased in group 1, although it
decreased in groups 2 and 3. Do you have
an explanation?
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Reply to the Editor:
We thank Drs Sersar, Jamjoom, and Baslaim
for their comments on our study.1
Shone complex was originally de-
scribed as comprising 4 coexisting obstruc-
tive lesions: Supravalvar ring of the left
atrium, “parachute” deformity of the mitral
valve, subaortic stenosis, and coarctation of
the aorta are considerably more challeng-
ing than is an isolated subaortic stenosis.
On the basis of mean values, there are
some differences in the left ventricular end-
systolic dimension between groups, despite
being statistically insignificant. This may
be attributable to differences in left ventric-
ular compliance to changes in loading con-
ditions. This remains to be reexamined in a
larger group of patients.
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